A California jury has awarded pharmaceutical drug company Merck $200 million, a fraction of what it had sought, for infringement of two of its patents
Author: Bruce Berman
Intellectual property observer, adviser, owner, author.
Validated Merck patents could mean a $3B+ windfall, after appeals
While many high-tech patents are suffering from devaluation the value of some pharmaceutical patents is soaring. Merck & Co. won a legal victory over
Survey: Almost half of all 2015 patent suits were filed in E.D. Texas
The Eastern District of Texas (E.D. Tx.) is responsible for almost half of all patent suits filed in 2015, and one judge, Rodney Gilstrap, is
Patent Quality Commissioner will provide performance update at Corporate IP Counsel Forum
Valencia Martin Wallace, Deputy Commissioner for Patent Quality at the United States Patent and Trademark Office, will deliver the keynote address at the USPTO’s Enhanced
Named on 40+ patents chemist sleeps in car on a Brooklyn Street
For more than a year a man slept in his SUV parked on the upscale Park Slope section of Brooklyn. The man, call him Gene,
“Secrets” is required reading for informed managers and investors
In an information age that worships data and transparency, the trade or business secret has never been more valuable. “Secrets” is an essential guide to
Technology companies back as top patent defendants in 2016
While it may seem like all of the patent infringement targets are large technology companies in 2015, at least 7 of the top 10 defendants
Algorithm: patent transactions have decreased 78% since 2013
If it seems like US patent transactions have fallen dramatically over past few years you are not imagining things, says a Chicago patent attorney. According
Burford Capital, Digimarc and Imagination added to IP CloseUp 30
Three public companies that are active in patent licensing or highly dependent on patents for success have been added to the IP CloseUp 30 index
PTAB instituted IPRs are flat after declining slightly in 2015
After declining 9% in 2015 from the 2014 fiscal year Patent Trial and Appeal Board-instituted inter partes reviews (IPRs) have leveled off. Instituted reviews were at 74%
Fintech patent competition: fierce, diverse, growing
Among the most watched areas for new patent value is financial technology, covering inventions in areas like authentication, mobile payments and wealth management. Fintech is
Responsible Patent Licensing is focus of Wall Street event
Not all patent licensing businesses are alike. “NPE 2016: The Business of Responsible Licensing,” scheduled for March 22 at the Convene conference in New York,
ipcloseup.com 